InsiderTrades

Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/

Accepted 2024-07-16 00:00:00 ET · period of report 2024-07-16 · accession 0001467437-24-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-07-16 2024-07-16 KEQU Phillips Elizabeth D VP - Human Resources M - OptEx $19.58 +9,000 15.3K +143% +$176.2K
D 2024-07-16 2024-07-16 KEQU Phillips Elizabeth D VP - Human Resources F - Tax $52.00 -5,854 15.4K -27% -$304.4K
DM 2024-07-16 2024-07-16 KEQU Phillips Elizabeth D VP - Human Resources M - OptEx — -9,000 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-16 M A 3,000 $16.97 18,295 D — — (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
2 Common Common Stock 2024-07-16 M A 3,000 $23.62 21,295 D — — (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
3 Common Common Stock 2024-07-16 F D 5,854 $52.00 15,441 D — — (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report. (F2) Also includes shares withheld by the company to discharge withholding tax obligations of the reporting person.
4 Common Common Stock 2024-07-16 M A 3,000 $18.14 15,295 D — — (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
5 Derivative Option to Buy FY16 2024-07-16 M D 3,000 — 0 D $16.97 · 2019-08-26 to 2025-08-26 3,000 Common Stock (F3) Employee stock option granted under Employee Stock Option plan under Rule 16b-3.
6 Derivative Option to Buy FY15 2024-07-16 M D 3,000 — 0 D $18.14 · 2018-08-27 to 2024-08-27 3,000 Common Stock (F3) Employee stock option granted under Employee Stock Option plan under Rule 16b-3.
7 Derivative Option to Buy FY17 2024-07-16 M D 3,000 — 0 D $23.62 · 2020-08-31 to 2026-08-31 3,000 Common Stock (F3) Employee stock option granted under Employee Stock Option plan under Rule 16b-3.